CRIXIVAN
- Product NDC
- 21695-366
- 11-digit product format
- 216950366
- Labeler code
- 21695
- Product ID
- 21695-366_01c5574c-1056-49c6-af20-e950db3f4139
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- indinavir sulfate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- NDA020685
- Marketing category
- NDA
- Marketing start
- 1996-03-13
- Marketing end
- 0000-00-00
- Substance
- INDINAVIR SULFATE
- Active strength
- 400 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| eed3583e-78db-412f-aba7-02811a2dc6a8 | Product name | 1 | 20150204 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-366-18 | 2019-09-24 | C162847 | 48780-1 | 934fe258-477f-48b1-e053-8cdaa90a720a | CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-366-18 | CRIXIVAN | 18 in 1 BOTTLE | CAPSULE | 18 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 21695-366-18 | EA - Each | 21695-366 | c81fdc1b-31e0-40f1-ad77-d2a6a32425c5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| INDINAVIR SULFATE | ACTIVE INGREDIENT | 771H53976Q | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| INDINAVIR | ACTIVE MOIETY | 5W6YA9PKKH | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 153128 | Crixivan 400 MG Oral Capsule | PSN | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir sulfate 400 MG Oral Capsule | PSN | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 153128 | indinavir 400 MG Oral Capsule [Crixivan] | SBD | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir 400 MG Oral Capsule | SCD | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 153128 | Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule | SY | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 153128 | Crixivan 400 MG Oral Capsule | SY | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
| 310988 | indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule | SY | 01c5574c-1056-49c6-af20-e950db3f4139 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 21695-366-18 | 21695036618 | 18 in 1 BOTTLE | Historical |